- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biofrontera AG (B8FKn)
Track today's live Biofrontera AG (B8FKn) share price, performance and key data on this page with our current Xetra:B8FKn stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Biofrontera AG share price on the Xetra exchange. Use the dropdown to switch exchange for the B8FKn share price, head to our technical summary section, which provides analysis on Biofrontera AG share price buy/sell indicators using real-time data (or discuss the Biofrontera AG (B8FKn) stock price today with other investors in the Biofrontera AG ETR share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ETR:B8FKn share price (ISIN: DE000A4BGGM7) to enhance your trading decisions with our free investment tools and resources.
What Is the Biofrontera AG Share Price Today?
The Biofrontera AG share price today is 2.350.
What Is the Stock Symbol for Biofrontera AG
The stock symbol (or 'ticker') for Biofrontera AG is "B8FKn."
What Stock Exchange Does Biofrontera AG Trade On?
Biofrontera AG is listed and trades on the Xetra stock exchange.
Is Biofrontera AG a Good Stock to Buy?
Determining whether Biofrontera AG (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current ETR:B8FKn share price (ISIN: DE000A4BGGM7) to enhance your trading decisions with our free investment tools and resources.
What Is the Biofrontera AG Share Price Today?
The Biofrontera AG share price today is 2.350.
What Is the Stock Symbol for Biofrontera AG
The stock symbol (or 'ticker') for Biofrontera AG is "B8FKn."
What Stock Exchange Does Biofrontera AG Trade On?
Biofrontera AG is listed and trades on the Xetra stock exchange.
Is Biofrontera AG a Good Stock to Buy?
Determining whether Biofrontera AG (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
2.350
+0.020(+0.86%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.300
2.390
52 wk Range
2.210
2.960
B8FKn is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.3002.390
52 wk Range
2.2102.960
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
B8FKn Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Earnings
Latest Release
03/06/2026
EPS / Forecast
0.01 / --
Revenue / Forecast
3.71M / --
Compare B8FKn to Peers and Sector
Metrics to compare | B8FKn | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipB8FKnPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.1x | 17.0x | −0.4x | |
PEG Ratio | 0.01 | −0.08 | 0.00 | |
Price/Book | 0.8x | 1.5x | 2.6x | |
Price / LTM Sales | 1.0x | 1.4x | 3.0x | |
Upside (Analyst Target) | - | 16.2% | 50.7% | |
Fair Value Upside | Unlock | 12.0% | 6.5% | Unlock |
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products and medical products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company offers Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also provides RhodoLED XL lamp for the treatment of multiple interspersed lesions; and Belixos, a cosmetic product for irritated and sensitive skin. In addition, the company focus on photodynamic therapy (PDT) for the treatment of actinic keratosis and keratinocyte skin cancers, including basal cell carcinoma. The company has a license and supply agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Biofrontera AG (Xetra: B8FKn) Share Price Today?
The Biofrontera AG stock price today is 2.350 EUR.
What Stock Exchange Does Biofrontera AG (B8FKn) Trade On?
Biofrontera AG is listed and trades on the Frankfurt Stock Exchange.
What Is the Ticker (Stock Symbol) for Biofrontera AG?
The stock symbol (also called a 'ticker') for Biofrontera AG is "B8FKn."
What Is the Current Biofrontera AG Market Capitalisation?
As of today, Biofrontera AG (Xetra: B8FKn) market cap is 14.280M EUR.
What Is Biofrontera AG's (B8FKn) Earnings Per Share (TTM)?
The Biofrontera AG EPS is currently -1.101 (Trailing Twelve Months).
When Is the Next Biofrontera AG Earnings Date?
Biofrontera AG's next earnings report will be released on 03/09/2026.
Is B8FKn a Buy or Sell From a Technical Analyst Perspective?
Based on today's Biofrontera AG moving averages and other technical indicators, the daily buy/sell signal for B8FKn stock is Sell.
How Many Times Has Biofrontera AG Stock Split?
Biofrontera AG has split 6 times. (See the B8FKn stock split history page for full effective split date and price information.)
How Many Employees Does Biofrontera AG Have?
Biofrontera AG has 69 employees, based on their latest Companies House report.
What is the current trading status of Biofrontera AG (Xetra: B8FKn)?
As of 03/07/2026, Biofrontera AG (B8FKn) is trading at a share price of 2.350 EUR, with a previous close of 2.330 EUR. The stock has fluctuated within a day range of 2.300 EUR to 2.390 EUR, while its 52-week range spans from 2.210 EUR to 2.960 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.